Suchergebnisse - "Merle, Philippe"

PubPharm (215)

1

Cabozantinib plus atezolizumab versus sorafenib for advanced hepatocellular carcinoma (COSMIC-312) : final results of a randomised phase 3 study

enthalten in: The lancet. Gastroenterology & hepatology | 2024

von Yau, T. | Kaseb, A. | Cheng, A. | +19

2

Long-term oncological results of percutaneous radiofrequency ablation for intrahepatic cholangiocarcinoma

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Alitti, C. | Rode, A. | Trillaud, H. | +13

3

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002) : a randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2023

von Llovet, J. | Kudo, M. | Merle, P. | +123

ErratumIn: Lancet Oncol. 2024 Apr;25(4):e137. - PMID 38547896

4

Unresectable hepatocellular carcinoma at dawn of immunotherapy era : real-world data from the French prospective CHIEF cohort

enthalten in: European journal of gastroenterology & hepatology | 2023

von Nguyen-Khac, E. | Nahon, P. | Ganry, O. | +23

5

Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma : Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial

enthalten in: Liver cancer | 2023

von Merle, P. | Kudo, M. | Edeline, J. | +17

6

Predictive and Prognostic Potential of Liver Function Assessment in Patients with Advanced Hepatocellular Carcinoma : A Systematic Literature Review

enthalten in: Liver cancer | 2023

von Vogel, A. | Kelley, R. | Johnson, P. | +5

7

Prognostic factors and survival prediction in hepatocellular carcinoma : development and validation of a novel nomogram based on the SEER database

enthalten in: Journal of gastrointestinal oncology | 2023

von Huang, S. | Zhu, Z. | Ruan, Y. | +7

CommentIn: J Gastrointest Oncol. 2024 Feb 29;15(1):533-534. - PMID 38482251

8

Hypersensitivity infusion-associated reactions induced by enzyme replacement therapy in a cohort of patients with late-onset Pompe disease : An experience from the French Pompe Registry

enthalten in: Molecular genetics and metabolism | 2023

von Lessard, L. | Tard, C. | Salort-Campana, E. | +11

9

Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIV

enthalten in: AIDS (London, England) | 2023

von Requena, M. | Grabar, S. | Lanoy, E. | +10

10

Regorafenib versus Cabozantinib as a Second-Line Treatment for Advanced Hepatocellular Carcinoma : An Anchored Matching-Adjusted Indirect Comparison of Efficacy and Safety

enthalten in: Liver cancer | 2023

von Merle, P. | Kudo, M. | Krotneva, S. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]